Jabil Packaging Solutions, a division of Jabil Inc. (St. Petersburg, Florida), recently launched a connected packaging platform that enables consumer packaged goods (CPG) companies to offer their customers a compelling next-generation user experience that maximises convenience and boosts brand loyalty. The new platform combines sensors, connectivity and cloud technologies to eliminate reorder friction for consumer staples. Leveraging Jabil’s specialised services, differentiated capabilities and turnkey products for connected packaging innovation and scale, the platform positions the company as one of the only packaging solutions providers to offer connected packaging services across the entire value chain.
The SUPERSMART research project funded by EIT RawMaterials has shown proof: printed electronic components such as sensors and smart labels on paper can play an essential role in building a smart environment for production, retail and logistics. Efficient and reliable production processes make them economically competitive. In terms of resource conservation, climate and the environment, electronics printed on paper have outstanding advantages over conventional substrates and manufacturing processes for smart electronic components. The SUPERSMART project team is proud to have been selected by the international jury as the winner of the 2021 OE-A competition within the category "Best Publicly Funded Project Demonstrator". The award ceremony took place on 15 April 2021.
During clinical trials of new drugs pharmaceutical companies must be able to depend on strict adherence to therapy regimens. However, up to 50 percent of patients involved in clinical trials do not adhere to the prescribed dosage regimen, resulting in distorted outcomes such as insufficient drug efficacy or underestimated frequency of side effects and delayed time to market. To enhance therapy adherence in clinical trials, Schreiner MediPharm (Oberschleißheim, Germany) and AARDEX Group (Seraing, Belgium) offer an electronic solution for medication adherence monitoring enabling pharmaceutical companies to digitally monitor and manage medication intake of their trial participants.